Abstract:Beginning in the 1960s, animal and cell culture studies have demonstrated that transcranial photobiomodulation (t-PBM), which involves photons in the red and near-infrared spectrum, can penetrate the cerebral cortex and enhance the mitochondrial electron transport chain [1] (fNIRS similarly uses near infrared photons to image the brain, but at lower light intensities and exposure, resulting in minimal impact on brain function). Emerging human t-PBM data have demonstrated behavioral and clinical effects in multiple patient populations, along with effects on cerebral metabolism and hemodynamics, highlighting its potential therapeutic efficacy [1]. For example, small studies suggested that t-PBM delivered with both high (700 mW/cm 2 ) and low (36 mW/cm 2 ) irradiance [2] is effective in the treatment of major depressive disorder (MDD). However, since other studies with low t-PBM irradiance (55 mW/cm 2 ) did not replicate the positive results in MDD [3], it becomes critically important to further understand the irradiance dose-dependent neurobiological mechanisms of t-PBM, as we are attempting in our ongoing clinical trial [4]. t-PBM has an excellent safety profile [1,2,3], and it can be performed in multiple settings, including during magnetic resonance imaging (MRI) or other neuroimaging modalities, to quantify the impact on brain bioenergetics noninvasively and in real-time. However, work is still underway to determine the optimal parameters for clinical utility. Our team has recently demonstrated the effect of t-PBM, at medium irradiance (300 mW/cm 2 ), on regional intrinsic brain activity in 19 individuals with early Alzheimer's disease [AD] [5]. In this publication [5], we found that t-PBM altered the fractional amplitude of low-frequency fluctuations (fALFF) across all laser-irradiated brain cortical regions, which are limited to frontal regions due to skull density and hair interference. fALFF, assessed non-invasively during resting-state MRI, is a voxel-based measure of intrinsic brain activity measuring the regional brain metabolism: it is strongly correlated with cerebral glucose metabolism measured by [ 18 F]Fluorodeoxyglucose positron emission tomography. Similarly, other studies have reported increases in MRI BOLD signal (also in t-PBM-irradiated brain areas, at 300 mW/cm 2 irradiance) in healthy volunteers [6]. The increase in fALFF we detected in t-PBM-irradiated brain areas during stimulation [5], and the similar increases in MRI BOLD signal [6], suggest that t-PBM can increase intrinsic brain activity (and specifically cerebral metabolism) in real time; these effects continue briefly after t-PBM administration has ended.

Raman Spectroscopy Reveals Photobiomodulation-Induced α-Helix to β-Sheet Transition in Tubulins: Potential Implications for Alzheimer's and Other Neurodegenerative Diseases

Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model

Photobiomodulation as a Potential Treatment for Alzheimer's Disease: A Review Paper

Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer’s Disease

Raman spectroscopy and its plasmon-enhanced counterparts: A toolbox to probe protein dynamics and aggregation

#neverforget - Photobiomodulation Against Alzheimer's Disease: A Systematic Review

Dual Photonics Probing of Nano- to Submicron-Scale Structural Alterations in Human Brain Tissues/Cells and Chromatin/DNA with the Progression of Alzheimer's Disease

Raman spectroscopy in the study of amyloid formation and phase separation

Photobiomodulation reduces hippocampal apoptotic cell death and produces a Raman spectroscopic "signature"

Photobiomodulation Therapy: A Novel Therapeutic Approach to Alzheimer's Disease Made Possible by the Evidence of a Brain-Gut Interconnection

Oxidative species-induced excitonic transport in tubulin aromatic networks: Potential implications for neurodegenerative disease

Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?

Near-infrared Irradiation Controlled Thermo-Switchable Polymeric Photosensitizer against β-Amyloid Fibrillation

Photobiomodulation in experimental models of Alzheimer's disease: state-of-the-art and translational perspectives

Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics

Label-free imaging of amyloid plaques in Alzheimer's disease with stimulated Raman scattering microscopy.

Unveiling the Structural Proteome of an Alzheimer's Disease Rat Brain Model

Infrared nanospectroscopy reveals the molecular interaction fingerprint of an aggregation inhibitor with single Aβ42 oligomers

Efficient 18.8 T MAS-DNP NMR reveals hidden side chains in amyloid fibrils

A Biocompatible Second Near-Infrared Nanozyme for Spatiotemporal and Non-Invasive Attenuation of Amyloid Deposition through Scalp and Skull

Effect of trans-cranial near infrared light 1068 nm upon age-related memory status: a pilot study.